Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature
Introduction Pharmacological therapy is recommended as a second-line alternative to
reverse obesity. Currently, five anti-obesity drugs (AODs) have been approved by the US …
reverse obesity. Currently, five anti-obesity drugs (AODs) have been approved by the US …
Neuroprotective potential of topiramate, pregabalin and lacosamide combination in a rat model of acute SE and intractable epilepsy: perspectives from …
The lithium-pilocarpine model is commonly used to recapitulate characteristics of human
intractable focal epilepsy. In the current study, we explored the impact of topiramate (TPM) …
intractable focal epilepsy. In the current study, we explored the impact of topiramate (TPM) …
Pharmacotherapy of obesity: state of the art and perspectives
K Sićović, A Micov - Archives of Pharmacy, 2024 - aseestant.ceon.rs
Obesity is a chronic, progressive, and recurring disease. The prevalence of obesity has
reached pandemic proportions, along with overweight-related conditions like diabetes …
reached pandemic proportions, along with overweight-related conditions like diabetes …
[PDF][PDF] Placebo–Placebo, Nocebo–Nocebo, Placebo–Nocebo, and Nocebo–Placebo Effects: A Review of Eastern and Western Perspectives
SS Jarali - osf.io
This study examined placebo and nocebo effects, characterized by classical conditioning,
operant conditioning, and expectancy effects. The placebo–placebo and nocebo–nocebo …
operant conditioning, and expectancy effects. The placebo–placebo and nocebo–nocebo …
[HTML][HTML] THE PCCA BLOG
S Hover - pccarx.com
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of
reproductive age world-wide. 1 The diagnostic criteria have changed over the last several …
reproductive age world-wide. 1 The diagnostic criteria have changed over the last several …